171 related articles for article (PubMed ID: 7735201)
1. Involvement of protease inhibitors in staphylokinase-induced fibrin-specific fibrinolysis.
Shishido Y; Sakai M; Kaneda N; Sansawa H; Shimura K; Hashimoto S; Yokokura T
Biol Pharm Bull; 1994 Dec; 17(12):1595-8. PubMed ID: 7735201
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of fibrin-specific fibrinolysis by staphylokinase: participation of alpha 2-plasmin inhibitor.
Sakai M; Watanuki M; Matsuo O
Biochem Biophys Res Commun; 1989 Jul; 162(2):830-7. PubMed ID: 2527034
[TBL] [Abstract][Full Text] [Related]
3. Fibrin-specific fibrinolysis induced by recombinant staphylokinase.
Shishido Y; Matsumoto T; Sakai M; Kaneda N; Sansawa H; Shimura K; Hashimoto S; Yokokura T
Biol Pharm Bull; 1994 Aug; 17(8):1060-4. PubMed ID: 7820108
[TBL] [Abstract][Full Text] [Related]
4. Analysis of plasminogen activation by the plasmin-staphylokinase complex in plasma of alpha2-antiplasmin-deficient mice.
Okada K; Ueshima S; Tanaka M; Fukao H; Matsuo O
Blood Coagul Fibrinolysis; 2000 Oct; 11(7):645-55. PubMed ID: 11085285
[TBL] [Abstract][Full Text] [Related]
5. A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity--a staphylokinase variant. I. In vitro study.
Szemraj J; Walkowiak B; Kawecka I; Janiszewska G; Buczko W; Bartkowiak J; Chabielska E
J Thromb Haemost; 2005 Oct; 3(10):2156-65. PubMed ID: 16150047
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of staphylokinase, streptokinase and tissue-type plasminogen activator on the lysis of retracted human plasma clots and fibrinolytic plasma parameters in vitro.
Hauptmann J; Glusa E
Blood Coagul Fibrinolysis; 1995 Sep; 6(6):579-83. PubMed ID: 7578902
[TBL] [Abstract][Full Text] [Related]
7. Effects of alpha 2-plasmin inhibitor on plasminogen activation by staphylokinase/plasminogen complex.
Okada K; Nonaka T; Matsumoto H; Fukao H; Ueshima S; Matsuo O
Thromb Res; 1994 Oct; 76(2):211-20. PubMed ID: 7863470
[TBL] [Abstract][Full Text] [Related]
8. Kinetic analysis of plasminogen activation by staphylokinase/plasminogen complex in the presence of fibrin.
Okada K; Yuasa H; Hagiya Y; Fukao H; Ueshima S; Matsuo O
Thromb Res; 1994 Oct; 76(2):181-91. PubMed ID: 7863467
[TBL] [Abstract][Full Text] [Related]
9. Thrombolytic agents.
Collen D; Lijnen HR
Thromb Haemost; 2005 Apr; 93(4):627-30. PubMed ID: 15841305
[TBL] [Abstract][Full Text] [Related]
10. Effects of endothelial cells on activity of staphylokinase.
Ueshima S; Okada K; Matsumoto H; Takaishi T; Fukao H; Matsuo O
Blood Coagul Fibrinolysis; 1996 Jul; 7(5):522-9. PubMed ID: 8874862
[TBL] [Abstract][Full Text] [Related]
11. Integration of VEK-30 peptide enhances fibrinolytic properties of staphylokinase.
Bhando T; Singh S; Hade MD; Kaur J; Dikshit KL
Biotechnol Appl Biochem; 2021 Apr; 68(2):213-220. PubMed ID: 32233032
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
[TBL] [Abstract][Full Text] [Related]
13. Complexing of tissue plasminogen activator with PAI-1, alpha 2-macroglobulin, and C1-inhibitor: studies in patients with defibrination and a fibrinolytic state after electroshock or complicated labor.
Bennett B; Croll A; Ferguson K; Booth NA
Blood; 1990 Feb; 75(3):671-6. PubMed ID: 1688722
[TBL] [Abstract][Full Text] [Related]
14. Staphylokinase reduces plasmin formation by endogenous plasminogen activators.
Jin T; Bokarewa M; Zhu Y; Tarkowski A
Eur J Haematol; 2008 Jul; 81(1):8-17. PubMed ID: 18331597
[TBL] [Abstract][Full Text] [Related]
15. Kinetic studies on the plasminogen activation by the staphylokinase-plasmin complex.
Shibata H; Nagaoka M; Sakai M; Sawada H; Watanabe T; Yokokura T
J Biochem; 1994 Apr; 115(4):738-42. PubMed ID: 8089091
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinase.
Collen D; Van Hoef B; Schlott B; Hartmann M; Gührs KH; Lijnen HR
Eur J Biochem; 1993 Aug; 216(1):307-14. PubMed ID: 7689966
[TBL] [Abstract][Full Text] [Related]
17. Functional properties of recombinant staphylokinase variants obtained by site-specific mutagenesis of methionine-26.
Schlott B; Hartmann M; Gührs KH; Birch-Hirschfeld E; Gase A; Vettermann S; Collen D; Lijnen HR
Biochim Biophys Acta; 1994 Feb; 1204(2):235-42. PubMed ID: 8142464
[TBL] [Abstract][Full Text] [Related]
18. Staphylokinase requires NH2-terminal proteolysis for plasminogen activation.
Schlott B; Gührs KH; Hartmann M; Röcker A; Collen D
J Biol Chem; 1997 Feb; 272(9):6067-72. PubMed ID: 9038231
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of physiological fibrinolysis.
Lijnen HR; Collen D
Baillieres Clin Haematol; 1995 Jun; 8(2):277-90. PubMed ID: 7549063
[TBL] [Abstract][Full Text] [Related]
20. On the mechanism of fibrin-specific plasminogen activation by staphylokinase.
Lijnen HR; Van Hoef B; De Cock F; Okada K; Ueshima S; Matsuo O; Collen D
J Biol Chem; 1991 Jun; 266(18):11826-32. PubMed ID: 2050679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]